Literature DB >> 3239594

Clinical identification of nondiabetic renal disease in diabetic patients with type I and type II disease presenting with renal dysfunction.

E Amoah1, J L Glickman, C D Malchoff, B C Sturgill, D L Kaiser, W K Bolton.   

Abstract

A retrospective study was done on 109 diabetic patients who had renal biopsies during 1974-1984 to determine factors identifying nondiabetic renal disease in patients with diabetes mellitus presenting with renal dysfunction. Six of 49 (12%) patients with type I and 17 of 60 (28%) with type II diabetes mellitus had other renal diseases, with or without diabetic glomerulosclerosis. Multivariate predictors of other renal disease in type I diabetes mellitus were duration less than 5 years (p less than 0.001), absence of proteinuria (p less than 0.001), and absence of neuropathy (p less than 0.05). In type II diabetes mellitus these were late age of onset (p less than 0.001), absence of neuropathy (p less than 0.05), and Caucasian race (p less than 0.005). Some patients with other diseases appeared to respond to therapy directed at their nondiabetic glomerulosclerosis disease. We emphasize the need to distinguish between the subgroup of diabetic patients with nondiabetic renal disease from the majority who have diabetic glomerulosclerosis alone. The latter group should be spared the discomforts, risks, and costs of a renal biopsy.

Entities:  

Mesh:

Year:  1988        PMID: 3239594     DOI: 10.1159/000167584

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  10 in total

1.  Non-Diabetic renal disease in Diabetes Mellitus: clinical features and renal biopsy findings.

Authors:  E C Yenigun; F Dede; R Ozturk; D Turgut; E Koc; S V Piskinpasa; N Ozkayar; A R Odabas
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

2.  Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.

Authors:  F He; X Xia; X F Wu; X Q Yu; F X Huang
Journal:  Diabetologia       Date:  2012-12-12       Impact factor: 10.122

Review 3.  The role of the pediatric nephrologist in the care of children with diabetes mellitus.

Authors:  P Lane; M Steffes; S M Mauer
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

Review 4.  Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelines.

Authors:  Philip A McFarlane; Sheldon W Tobe; Bruce Culleton
Journal:  Can J Cardiol       Date:  2007-05-15       Impact factor: 5.223

5.  Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetes mellitus. The case of mainland France and of overseas French territories.

Authors:  D J Cordonnier; D Zmirou; P Y Benhamou; S Halimi; F Ledoux; J Guiserix
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

6.  The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.

Authors:  M A Gall; F S Nielsen; U M Smidt; H H Parving
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  The Relationship between Estimated Glomerular Filtration Rate and Diabetic Retinopathy.

Authors:  Jingyang Wu; Jin Geng; Limin Liu; Weiping Teng; Lei Liu; Lei Chen
Journal:  J Ophthalmol       Date:  2015-03-18       Impact factor: 1.909

8.  Nondiabetic kidney disease in type 2 diabetic patients: A single center experience.

Authors:  U Das; K V Dakshinamurty; A Prayaga; M S Uppin
Journal:  Indian J Nephrol       Date:  2012-09

9.  Is the presence of retinopathy of practical value in defining cases of diabetic nephropathy in genetic association studies? The experience with the ACE insertion/deletion polymorphism in 53 studies comprising 17,791 subjects.

Authors:  Daniel P K Ng; Bee-Choo Tai; Xiu-Li Lim
Journal:  Diabetes       Date:  2008-06-03       Impact factor: 9.461

10.  Fisher's Linear Discriminant Function Analysis and its Potential Utility as a Tool for the Assessment of Health-and-Wellness Programs in Indigenous Communities.

Authors:  Eric N Liberda; Aleksandra M Zuk; Ian D Martin; Leonard J S Tsuji
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.